Contouring of emerging organs-at-risk (OARS) of the female pelvis and interobserver variability: a study by the Italian association of radiotherapy and clinical oncology (AIRO)

被引:0
|
作者
Augurio, A. [1 ]
Macchia, G. [2 ]
Caravatta, L. [1 ]
Lucarelli, M. [3 ]
Di Gugliemo, F.
Vinciguerra, A. [1 ]
Seccia, B. [4 ]
De Sanctis, V. [5 ]
Autorino, R. [6 ]
Delle Curti, C.
Meregalli, S. [8 ]
Perrucci, E. [9 ]
Raspanti, D. [10 ]
Cerrotta, A. [7 ]
机构
[1] SS Annunziata Hosp, Dept Radiat Oncol, Via Vestini, I-66100 Chieti, Italy
[2] Univ Cattolica Sacro Cuore, Gemelli Molise Hosp, Radiat Oncol Unit, Largo Agostino Gemelli 1, I-86100 Campobasso, Italy
[3] Univ G dAnnunzio, SS Annunziata Hosp, Dept Radiot Oncol, Via Vestini, I-66100 Chieti, Italy
[4] Univ G dAnnunzio, Dept Neurosci Imaging & Clin Sci, Via Luigi Polacchi 11, I-66100 Chieti, Italy
[5] Sapienza Univ Rome, S Andrea Hosp, Dept Med & Surg & Translat Med, Radiotherapy Oncol, Via Grottarossa 1035, I-00189 Rome, Italy
[6] Fdn Policlin Univ A Gemelli IRCCS, Dept Diagnost Imaging, Oncol Radiotherapy Unit, Oncol Radiotherapy & Hematol, Via Giuseppe Moscati 31, I-00168 Rome, Italy
[7] Ist Nazl Tumori Milano, Fdn IRCS, Radioterapia Oncolog, Via Giacomo Venezian 1, I-20133 Milan, Italy
[8] Azienda Osped San Gerardo, Radiotherapy Unit, Via GB Pergolesi 33, I-20900 Monza, Italy
[9] Perugia Gen Hosp, Radiat Oncol Sect, Piazzale Giorgio Menghini 3, I-06129 Perugia, Italy
[10] Temasinergie SpA, Via Marcello Malpighi 120, Faenza, Italy
关键词
Emerging female pelvic OARs; Contouring atlas; Interobserver variability; Radiotherapy; Gynecological cancer; MODULATED RADIATION-THERAPY; TARGET VOLUME DELINEATION; ADVANCED CERVICAL-CANCER; GUIDED ADAPTIVE BRACHYTHERAPY; PROSTATE-CANCER; FLOOR MUSCLES; LATE TOXICITY; RECOMMENDATIONS; CHEMORADIATION; INCONTINENCE;
D O I
10.1016/j.ctro.2023.100688
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To provide straightforward instructions for daily practice in delineating emerging organs-at-risk (OARs) of the female pelvis and to discuss the interobserver variability in a two-step multicenter study.Methods and materials: A contouring atlas with anatomical boundaries for each emerging OAR was realized by radiation oncologists and radiologists who are experts in pelvic imaging, as per their knowledge and clinical practice. These contours were identified as quality benchmarks for the analysis subsequently carried out. Radiation oncologists not involved in setting the custom-built contouring atlas and interested in the treatment of gynecological cancer were invited to participate in this 2-step trial. In the first step all participants were supplied with a selected clinical case of locally advanced cervical cancer and had to identify emerging OARs (Levator ani muscle; Puborectalis muscle; Internal anal sphincter; External anal sphincter; Bladder base and trigone; Bladder neck; Iliac Bone Marrow; Lower Pelvis Bone Marrow; Lumbosacral Bone Marrow) based on their own personal knowledge of pelvic anatomy and experience. The suggested OARs and the contouring process were then presented at a subsequent webinar meeting with a contouring laboratory. Finally, in the second step, after the webinar meeting, each participant who had joined the study but was not involved in setting the benchmark received the custom-built contouring atlas with anatomical boundaries and was requested to delineate again the OARs using the tool provided. The Dice Similarity Coefficient (DSC) and the Jaccard Similarity Coefficient (JSC) were used to evaluate the spatial overlap accuracy of the different volume delineations and compared with the benchmark; the Hausdorff distance (HD) and the mean distance to agreement (MDA) to explore the distance between contours. All the results were reported as sample mean and standard deviation (SD). Results: Fifteen radiation oncologists from different Institutions joined the study. The participants had a high agreement degree for pelvic bones sub-structures delineation according to DICE (IBM: 0.9 +/- 0.02; LPBM: 0.91 +/- 0.01). A moderate degree according to DICE was showed for ovaries (Right: 0.61 +/- 0.16, Left: 0.72 +/- 0.05), vagina (0.575 +/- 0.13), bladder sub-structures (0.515 +/- 0.08) and EAS (0.605 +/- 0.05), whereas a low degree for the other sub-structures of the anal-rectal sphincter complex (LAM: 0.345 +/- 0.07, PRM: 0.41 +/- 0.10, and IAS: 0.4 +/- 0.07).Conclusion: This study found a moderate to low level of agreement in the delineation of the female pelvis emerging OARs, with a high degree of variability among observers. The development of delineation tools should be encouraged to improve the routine contouring of these OARs and increase the quality and consistency of radiotherapy planning.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Inter-observer variability of clinical target volume delineation in definitive radiotherapy of neck lymph node metastases from unknown primary. A cooperative study of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) Head and Neck Group
    Trignani, Marianna
    Argenone, Angela
    Di Biase, Saide
    Musio, Daniela
    Merlotti, Anna
    Ursino, Stefano
    Orlandi, Ester
    Genovesi, Domenico
    Bacigalupo, Almalina
    RADIOLOGIA MEDICA, 2019, 124 (07): : 682 - 692
  • [32] The role of radiation therapy technologist in interventional radiotherapy (brachytherapy) in Italy: Italian Association of Radiotherapy and Clinical Oncology (AIRO) and Italian Association of Radiation Therapy and Medical Physics Technologists (AITRO) joint project
    Cornacchione, Patrizia
    Tagliaferri, Luca
    D'Aviero, Andrea
    Ciabattoni, Antonella
    Galdieri, Carmela
    De Sanctis, Vitaliana
    Fellin, Francesco
    Gribaudo, Sergio
    Lambertini, Daniele
    Gambacorta, Maria Antonietta
    Jereczek-Fossa, Barbara
    Donato, Vittorio
    Vavassori, Andrea
    JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2021, 13 (06) : 599 - 604
  • [33] Radiotherapy and temozolomide in anaplastic astrocytoma: a retrospective multicenter study by the Central Nervous System Study Group of AIRO (Italian Association of Radiation Oncology)
    Scoccianti, Silvia
    Magrini, Stefano Maria
    Ricardi, Umberto
    Detti, Beatrice
    Krengli, Marco
    Parisi, Salvatore
    Bertoni, Filippo
    Sotti, Guido
    Cipressi, Samantha
    Tombolini, Vincenzo
    Dall'Oglio, Stefano
    Lioce, Marco
    Saieva, Calogero
    Buglione, Michela
    Mantovani, Cristina
    Rubino, Giovanni
    Muto, Paolo
    Fusco, Vincenzo
    Fariselli, Laura
    de Renzis, Costantino
    Masini, Laura
    Santoni, Riccardo
    Pirtoli, Luigi
    Biti, Giampaolo
    NEURO-ONCOLOGY, 2012, 14 (06) : 798 - 807
  • [34] Inter-observer variability of clinical target volume delineation in definitive radiotherapy of neck lymph node metastases from unknown primary. A cooperative study of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) Head and Neck Group
    Marianna Trignani
    Angela Argenone
    Saide Di Biase
    Daniela Musio
    Anna Merlotti
    Stefano Ursino
    Ester Orlandi
    Domenico Genovesi
    Almalina Bacigalupo
    La radiologia medica, 2019, 124 : 682 - 692
  • [35] PAIDEIA: pacemaker and implanted cardioverter defibrillator management in radiation therapy—a survey by the Young Group of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)
    Anna Rita Alitto
    Silvia Chiesa
    Pierfrancesco Franco
    Michele Fiore
    Lorenza Marino
    Paolo Borghetti
    Isacco Desideri
    Daniela Greto
    Alba Fiorentino
    La radiologia medica, 2020, 125 : 329 - 335
  • [36] Pattern of practice of re-irradiation for ipsilateral breast tumor recurrence in Italy: a survey by the Italian Association of Radiotherapy and Clinical Oncology (AIRO)
    Massaccesi, Mariangela
    Fontana, Antonella
    Palumbo, Isabella
    Argenone, Angela
    De Santis, Maria Carmen
    Masiello, Valeria
    Pontoriero, Antonio
    Ciabattoni, Antonella
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (03): : 644 - 652
  • [37] Pattern of practice of re-irradiation for ipsilateral breast tumor recurrence in Italy: a survey by the Italian Association of Radiotherapy and Clinical Oncology (AIRO)
    Mariangela Massaccesi
    Antonella Fontana
    Isabella Palumbo
    Angela Argenone
    Maria Carmen De Santis
    Valeria Masiello
    Antonio Pontoriero
    Antonella Ciabattoni
    Clinical and Translational Oncology, 2024, 26 : 644 - 652
  • [38] A Pattern of Care Report on the Management of Patients with Squamous Cell Carcinoma of the Anus-A Study by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) Gastrointestinal Tumors Study Group
    Franco, Pierfrancesco
    Chiloiro, Giuditta
    Montesi, Giampaolo
    Montrone, Sabrina
    Arcelli, Alessandra
    Comito, Tiziana
    Arcadipane, Francesca
    Caravatta, Luciana
    Macchia, Gabriella
    Lupattelli, Marco
    Niespolo, Marina Rita
    Munoz, Fernando
    Palazzari, Elisa
    Krengli, Marco
    Valvo, Francesca
    Gambacorta, Maria Antonietta
    Genovesi, Domenico
    Mantello, Giovanna
    MEDICINA-LITHUANIA, 2021, 57 (12):
  • [39] Post-operative management of brain metastases: GRADE-based clinical practice recommendations on behalf of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)
    Chiara Reverberi
    Stefania Volpe
    Damiano Balestrini
    Michela Buglione
    Piera Navarria
    Silvia Scoccianti
    Pierpaolo Panciani
    Marco Krengli
    Luigi Pirtoli
    Lorenzo Bordi
    Giovanni L. Pappagallo
    Rolando M. D.’ Angelillo
    Stefano M. Magrini
    Stefano Arcangeli
    Journal of Cancer Research and Clinical Oncology, 2021, 147 : 793 - 802
  • [40] Post-operative management of brain metastases: GRADE-based clinical practice recommendations on behalf of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)
    Reverberi, Chiara
    Volpe, Stefania
    Balestrini, Damiano
    Buglione, Michela
    Navarria, Piera
    Scoccianti, Silvia
    Panciani, Pierpaolo
    Krengli, Marco
    Pirtoli, Luigi
    Bordi, Lorenzo
    Pappagallo, Giovanni L.
    Angelillo, Rolando M. D.
    Magrini, Stefano M.
    Arcangeli, Stefano
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (03) : 793 - 802